Fieldpoint Private Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$7K Hold
200
﹤0.01% 836
2022
Q1
$14K Hold
200
﹤0.01% 986
2021
Q4
$18K Sell
200
-50
-20% -$5.98K ﹤0.01% 903
2021
Q3
$32K Buy
250
+50
+25% +$7.28K 0.01% 691
2021
Q2
$29K Hold
200
0.01% 700
2021
Q1
$36K Hold
200
0.01% 639
2020
Q4
$40K Buy
+200
New +$40.7K 0.01% 514
2020
Q2
Sell
-2,758
Closed -$427K 287
2020
Q1
$427K Sell
2,758
-747
-21% -$86.9K 0.16% 146
2019
Q4
$293K Buy
3,505
+2,189
+166% +$167K 0.09% 215
2019
Q3
$89K Sell
1,316
-113
-8% -$7.44K 0.03% 311
2019
Q2
$95K Buy
+1,429
New +$83.3K 0.03% 339

Other funds holding TDOC

Fieldpoint Private Securities's TDOC Position: Q2 2022 in Review

Fieldpoint Private Securities held its Teladoc Health (TDOC) position steady in Q2 2022 at 200 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Fieldpoint Private Securities first reported a position in TDOC in Q2 2019 and has held it in 11 quarters since. The position peaked at $427K in Q1 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Fieldpoint Private Securities held 200 shares of Teladoc Health worth $7K as of Q2 2022.
  • Fieldpoint Private Securities left its Teladoc Health share count unchanged in Q2 2022.
  • Teladoc Health made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #836 holding.
  • Fieldpoint Private Securities first reported a position in Teladoc Health in Q2 2019 and has held it in 11 quarters since.
  • Fieldpoint Private Securities's Teladoc Health position peaked at $427K in Q1 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.